Kombiglyze

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Metformin hydrochloride 500mg;  ; Saxagliptin 2.5mg

Disponible depuis:

AstraZeneca Limited

DCI (Dénomination commune internationale):

Metformin hydrochloride 500 mg

Dosage:

2.5mg/500mg

forme pharmaceutique:

Film coated tablet

Composition:

Active: Metformin hydrochloride 500mg   Saxagliptin 2.5mg Excipient: Hydrochloric acid Magnesium stearate Opacode blue S-1-10619 Opadry pink 85F14452 Opadry white 85F18422 Povidone Purified water

Type d'ordonnance:

Prescription

Fabriqué par:

Merck Sante SAS

indications thérapeutiques:

Kombiglyze is indicated as an adjunct to diet & exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin & metformin is appropriate.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, - 56 tablets - 2 years from date of manufacture stored at or below 25°C

Date de l'autorisation:

2013-12-12